Quality of life in patients treated with aflibercept and FOLFIRI for metastatic colorectal cancer: interim analysis with focus on therapy lines of the non -interventional study QoLiTrap (AlO-LQ-0113)

被引：0

作者：

Hofheinz, R. ^{[1
]}

Scholten, F. ^{[2
]}

Derigs, H. ^{[2
]}

Thaler, J. ^{[3
]}

von Moos, R. ^{[1
,4
]}

机构：

[1] Univ Hosp Mannheim, Mannheim, Germany

[2] Klinikum Frankfurt Hoechst GmbH, Frankfurt, Germany

[3] Klinikum Wels Grieskirchen GmbH, Wels, Austria

[4] Kantonsspital Graubuenden, Chur, Switzerland

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PD - 026

引用

页码：118 / 118

页数：1

共 50 条

[1] Quality of life (QoL) in patients with aflibercept (AFL) and FOLFIRI for metastatic colorectal cancer (mCRC) - interim analysis with focus on mutational status of the non-interventional study QoLiTrap (AIO-LQ-0113)
von Moos, R.
Scholten, F.
Derigs, H. -G.
Gruenberger, B.
Thaler, J.
Hofheinz, R. -D.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 55 - 55
[2] Quality of life (QoL) in patients with aflibercept (AFL) and FOLFIRI for metastatic colorectal cancer (mCRC): Interim analysis with focus on mutational status of the non-interventional study QoLiTrap (AIO-LQ0113)
von Moos, R.
Scholten, F.
Derigs, H-G.
Gruenberger, B.
Thaler, J.
Hofheinz, R. D.
ANNALS OF ONCOLOGY, 2019, 30
[3] Analysis of the quality of life in patients treated with Aflibercept and FOLFIRI for metastatic colorectal cancer (mCRC) - Interim results from the non-interventional QoLiTrap study
Derigs, H. -G
Scholten, F.
Losem, C.
Kroening, H.
Windemuth-Kieselbach, C.
Hofheinz, R. -D
Oncology Research and Treatment, 2015, 38 : 61 - 62
[4] Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI - Interim results of the non-interventional study QoLiTrap
Scholten, F.
Derigs, G.
Losem, C.
Kroening, H.
Windemuth-Kieselbach, C.
Hofheinz, R. D.
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 163 - 163
[5] Quality of life in patients with aflibercept and FOLFIRI for metastatic colorectal cancer: final analysis of the non-interventional study QoLiTrap
von Moos, R.
Pederiva, S.
Anchisi, S.
Bohanes, P.
Thaler, J.
Hofheinz, R. -D.
SWISS MEDICAL WEEKLY, 2020, : 27S - 27S
[6] Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI - Interim results of the non-interventional AIO study QoLiTrap
von Moos, R.
Derigs, G.
Scholten, F.
Thaler, J.
Losem, C.
Kroening, H.
Windemuth-Kieselbach, C.
Hofheinz, R. D.
ANNALS OF ONCOLOGY, 2017, 28
[7] Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI: Interim results of the non-interventional AIO study QoLiTrap
Zahn, M.
Scholten, F.
von Moos, R.
Thaler, J.
Hofheinz, R.
ANNALS OF ONCOLOGY, 2018, 29
[8] Final results of the non-interventional study QoLiTrap (AIOLQ-0113) in patients with metastatic colorectal cancer (mCRC) treated with aflibercept plus FOLFIRI
Scholten, F.
von Moos, R.
Derigs, H. -G.
Hofheinz, R. -D.
Thaler, J.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 128 - 128
[9] Interim analysis of the non-interventional study QoLiTrap (AIO-LQ-0113) in patients with metastatic colorectal cancer (mCRC) treated with aflibercept (AFL) ± FOLFIRI: Efficacy according to age group ≤65 and >65 years
Hofheinz, R. D.
Derigs, H-G.
Piringer, G.
von Moos, R.
ANNALS OF ONCOLOGY, 2018, 29
[10] Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI - Interim results of the non-interventional AIO study QoLiTrap (AIO-LQ-0113) according to age group ≤65 and >65 years with the main focus on QoL and safety
Piringer, G.
Thaler, J.
Kroening, H.
Maintz, C.
von Moos, R.
Hofheinz, R. -D
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 288 - 288

← 1 2 3 4 5 →